Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 6, 2007, Pages 1098-1110

  Haim, Todd E ^a   Dowell, Candice ^a   Diamanti, Theodhor ^a   Scheuer, James ^a   Tardiff, Jil C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium; Cardiac Troponin T; Familial Hypertrophic Cardiomyopathy; Sarcomeric Mechanics; SERCA2a; Sudden Cardiac Death

Indexed keywords

TROPONIN T;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MOUSE; MUSCLE FIBER CONTRACTION; MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CALCIUM; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; KINETICS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; MYOCARDIAL CONTRACTION; MYOCARDIUM; TROPONIN T;

EID: 34249697644     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.03.906     Document Type: Article

References (54)

1. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 10 (2002 (Mar 13)) 1308-1320
2. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77 5 (Jun 3 1994) 701-712
3. Bonne G., Carrier L., Bercovici J., Cruaud C., Richard P., Hainque B., et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat. Genet. 11 4 (Dec 1995) 438-440
4. Satoh M., Takahashi M., Sakamoto T., Hiroe M., Marumo F., and Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem. Biophys. Res. Commun. 262 2 (1999 (Aug 27)) 411-417
5. Watkins H., Seidman J.G., and Seidman C.E. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum. Mol. Genet. 4 (1995) 1721-1727 [Spec No]
6. Fatkin D., and Graham R.M. Molecular mechanisms of inherited cardiomyopathies. Physiol. Rev. 82 4 (2002 (Oct)) 945-980
7. Watkins H., Anan R., Coviello D.A., Spirito P., Seidman J.G., and Seidman C.E. A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy. Circulation 91 9 (1995 (May 1)) 2302-2325
8. Moolman J.C., Corfield V.A., Posen B., Ngumbela K., Seidman C., Brink P.A., et al. Sudden death due to troponin T mutations. J. Am. Coll. Cardiol. 29 3 (1997 (Mar 1)) 549-555
9. Sorajja P., Elliott P.M., and McKenna W.J. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications. Europace 2 1 (2000 (Jan)) 4-14
10. Palm T., Graboski S., Hitchcock-DeGregori S.E., and Greenfield N.J. Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys. J. 81 5 (2001 (Nov)) 2827-2837
11. Hinkle A., and Tobacman L.S. Folding and function of the troponin tail domain. Effects of cardiomyopathic troponin T mutations. J. Biol. Chem. 278 1 (2003 (Jan 3)) 506-513
12. Ertz-Berger B.R., He H., Dowell C., Factor S.M., Haim T.E., Nunez S., et al. Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 102 50 (2005 (Dec 13)) 18219-18224
13. Forissier J.F., Carrier L., Farza H., Bonne G., Bercovici J., Richard P., et al. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 94 12 (1996 (Dec 15)) 3069-3073
14. Knollmann B.C., Kirchhof P., Sirenko S.G., Degen H., Greene A.E., Schober T., et al. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling. Circ. Res. 92 4 (2003 (Mar 7)) 428-436
15. Harada K., and Potter J.D. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction. J. Biol. Chem. 279 15 (2004 (Apr 9)) 14488-14495
16. Chandra M., Tschirgi M.L., and Tardiff J.C. Increase in tension-dependent ATP consumption induced by cardiac Tropnin T mutation. Am. J. Physiol. 289 5 (2005) H112-H119
17. Gomes A.V., Barnes J.A., Harada K., and Potter J.D. Role of troponin T in disease. Mol. Cell. Biochem. 263 1-2 (2004 (Aug)) 115-129
18. Nagata K., Liao R., Eberli F.R., Satoh N., Chevalier B., Apstein C.S., et al. Early changes in excitation-contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes. Cardiovasc. Res. 37 2 (1998 (Feb)) 467-477
19. Tardiff J.C., Hewett T.E., Palmer B.M., Olsson C., Factor S.M., Moore R.L., et al. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J. Clin. Invest. 104 4 (1999 (Aug)) 469-481
20. Bassani R.A., Bassani J.W., and Bers D.M. Mitochondrial and sarcolemmal Ca2+ transport reduce [Ca2+]i during caffeine contractures in rabbit cardiac myocytes. J. Physiol. 453 (1992) 591-608
21. Bers D.M. Excitation-contraction coupling and cardiac contractile force. Second ed. (2001), Kluwer Academic Publishers, The Netherlands
22. Evans C.C., Pena J.R., Phillips R.M., Muthuchamy M., Wieczorek D.F., Solaro R.J., et al. Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy. Am. J. Physiol. 279 5 (2000 (Nov)) H2414-H2423
23. Harrer J.M., Kiss E., and Kranias E.G. Application of the immunoblot technique for quantitation of protein levels in cardiac homogenates. BioTechniques 18 6 (1995 (Jun)) 995-998
24. Tardiff J.C., Factor S.M., Tompkins B.D., Hewett T.E., Palmer B.M., Moore R.L., et al. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J. Clin. Invest. 101 12 (1998 (Jun 15)) 2800-2811
25. Chandra M., Rundell V.L., Tardiff J.C., Leinwand L.A., De Tombe P.P., and Solaro R.J. Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am. J. Physiol. 280 2 (2001 (Feb)) H705-H713
26. Montgomery D.E., Tardiff J.C., and Chandra M. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice. J. Physiol. 536 Pt. 2 (2001 (Oct 15)) 583-592
27. Gwathmey J.K., Hajjar R.J., and Solaro R.J. Contractile deactivation and uncoupling of crossbridges. Effects of 2,3-butanedione monoxime on mammalian myocardium. Circ. Res. 69 5 (1991 (Nov)) 1280-1292
28. Belke D.D., Swanson E.A., and Dillmann W.H. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53 12 (2004 (Dec)) 3201-3208
29. Olsson M.C., Palmer B.M., Stauffer B.L., Leinwand L.A., and Moore R.L. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Circ. Res. 94 2 (2004 (Feb 6)) 201-207
30. Watkins H., McKenna W.J., Thierfelder L., Suk H.J., Anan R., O'Donoghue A., et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332 16 (1995 (Apr 20)) 1058-1064
31. Maass A.H., Ikeda K., Oberdorf-Maass S., Maier S.K., and Leinwand L.A. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation 110 15 (2004 (Oct 12)) 2102-2109
32. Tardiff J.C. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail. Rev. 10 3 (2005 (Sep)) 237-248
33. Kadambi V.J., Ponniah S., Harrer J.M., Hoit B.D., Dorn G.W., Walsh R.A., et al. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J. Clin. Invest. 97 2 (1996 (Jan 15)) 533-539
34. Janssen P.M., Stull L.B., and Marban E. Myofilament properties comprise the rate-limiting step for cardiac relaxation at body temperature in the rat. Am. J. Physiol. 282 2 (2002 (Feb)) H499-H507
35. Coutu P., Bennett C.N., Favre E.G., Day S.M., and Metzger J.M. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations. Circ. Res. 94 9 (2004 (May 14)) 1235-1241
36. Tobacman L.S. Thin filament-mediated regulation of cardiac contraction. Annu. Rev. Physiol. 58 (1996) 447-481
37. Tobacman L.S., Lin D., Butters C., Landis C., Back N., Pavlov D., et al. Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy. J. Biol. Chem. 274 40 (1999 (Oct 1)) 28363-28370
38. Spindler M., Saupe K.W., Christe M.E., Sweeney H.L., Seidman C.E., Seidman J.G., et al. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J. Clin. Invest. 101 8 (1998 (Apr 15)) 1775-1783
39. Javadpour M.M., Tardiff J.C., Pinz I., and Ingwall J.S. Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J. Clin. Invest. 112 5 (2003 (Sep)) 768-775
40. Schwartz K., and Mercadier J.J. Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair. J. Clin. Invest. 112 5 (2003 (Sep)) 652-654
41. Kim S.J., Iizuka K., Kelly R.A., Geng Y.J., Bishop S.P., Yang G., et al. An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am. J. Physiol. 276 5 Pt 2 (1999 (May)) H1780-H1787
42. Palmer B.M., Fishbaugher D.E., Schmitt J.P., Wang Y., Alpert N.R., Seidman C.E., et al. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium. Am. J. Physiol. 287 1 (2004 (Jul)) H91-H99
43. Maron B.J., Bonow R.O., Cannon R.O., Leon M.B., and Epstein S.E. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N. Engl. J. Med. 316 13 (1987 (Mar 26)) 780-789
44. Song Q., Schmidt A.G., Hahn H.S., Carr A.N., Frank B., Pater L., et al. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J. Clin. Invest. 111 6 (2003 (Mar)) 859-867
45. Bers D.M., Eisner D.A., and Valdivia H.H. Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport. Circ. Res. 93 6 (2003 (Sep 19)) 487-490
46. Ito K., Yan X., Tajima M., Su Z., Barry W.H., and Lorell B.H. Contractile reserve and intracellular calcium regulation in mouse myocytes from normal and hypertrophied failing hearts. Circ. Res. 87 7 (2000 (Sep 29)) 588-595
47. Zheng M., Dilly K., Dos Santos Cruz J., Li M., Gu Y., Ursitti J.A., et al. Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart. Am. J. Physiol. 286 1 (2004 (Jan)) H424-H433
48. Meyer M., Belke D.D., Trost S.U., Swanson E., Dieterle T., Scott B., et al. A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation. FASEB J. 18 11 (2004 (Aug)) 1312-1314
49. Terracciano C.M., Hardy J., Birks E.J., Khaghani A., Banner N.R., and Yacoub M.H. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 109 19 (2004 (May 18)) 2263-2265
50. Pathak A., del Monte F., Zhao W., Schultz J.E., Lorenz J.N., Bodi I., et al. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ. Res. 96 7 (2005 (Apr 15)) 756-766
51. Bers D.M. Calcium fluxes involved in control of cardiac myocyte contraction. Circ. Res. 87 4 (2000 (Aug 18)) 275-281
52. McElhinny A.S., Kazmierski S.T., Labeit S., and Gregorio C.C. Nebulin: the nebulous, multifunctional giant of striated muscle. Trends Cardiovasc. Med. 13 5 (2003 (Jul)) 195-201
53. McElhinny A.S., Schwach C., Valichnac M., Mount-Patrick S., and Gregorio C.C. Nebulin regulates the assembly and lengths of the thin filaments in striated muscle. J. Cell Biol. 170 6 (2005 (Sep 12)) 947-957
54. Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999 (May 3);(6):596-1601.